25+ Years of Commitment… and Still Going Strong for the HIV Community

With our heritage in the HIV space, today is not only commemorative, but also an opportunity to show solidarity with the millions of people living with HIV worldwide.

Thanks to the tireless efforts of medical professionals, today, HIV/AIDS is no longer considered a terminal diagnosis, but rather a chronic, manageable disease. But there is still room for advancement.

In the spirit of World AIDS Day’s 2022 theme, “Putting Ourselves to the Test: Achieving Equity to End HIV,” it’s the perfect time to acknowledge our HIV medical colleagues and their steadfast efforts to infuse new information and research into the HIV community.

Last year was the 25-year anniversary of the FDA approval of our HIV-associated wasting (HIVAW) medication, marking our long-standing commitment to the HIV community. And the release of new real-world evidence (RWE) at Miami CFAR that year suggested that HIVAW remains a prevalent comorbidity despite modern antiretroviral therapy.

Our prolific contribution to the advancement of treating and understanding HIVAW continued this year, as our Medical team generated and disseminated updated RWE data on HIVAW prevalence, incidence and economic burden, with publications in AIDS and Journal of Managed Care + Specialty Pharmacy and presentations at The American Conference for the Treatment of HIV (ACTHIV), Infectious Diseases Society of America’s IDWeek, and the HIV Glasgow Conference.

These evidence-based data aim to help healthcare professionals make better informed treatment decisions to achieve patient-centered care. Furthermore, these RWE data have identified potential predictors of incident HIVAW cases in specific vulnerable populations.

For many of our team members at EMD Serono, HIV has been the defining disease of their generation and the impetus behind their career focus. EMD Serono is privileged and grateful to have such dedicated professionals advancing scientific understanding for those in the HIV community, as we continue on our mission to help create, improve and prolong lives.